{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:46:18Z","timestamp":1793295978942,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.berh.2011.10.009","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T19:13:32Z","timestamp":1323371612000},"page":"469-483","source":"Crossref","is-referenced-by-count":107,"title":["Co-morbidities in established rheumatoid arthritis"],"prefix":"10.1016","volume":"25","author":[{"given":"Nicola J.","family":"Gullick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2011.10.009_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Journal of Chronic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","article-title":"The development of a comorbidity index with physical function as the outcome","volume":"58","author":"Groll","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.berh.2011.10.009_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0021-9681(74)90017-4","article-title":"The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus","volume":"27","author":"Kaplan","year":"1974","journal-title":"Journal of Chronic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data","volume":"45","author":"Von Korff","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.berh.2011.10.009_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005650-199302000-00005","article-title":"The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement","volume":"31","author":"Greenfield","year":"1993","journal-title":"Medical Care"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard.2008.098038","article-title":"Why do people with rheumatoid arthritis still die prematurely?","volume":"67","author":"Gabriel","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","article-title":"Mortality in established rheumatoid arthritis","volume":"21","author":"Naz","year":"2007","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib8","doi-asserted-by":"crossref","unstructured":"Kapetanovic M, Lindqvist E, Geborek P, Saxne T, Eberhard K. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s. Scandinavian Journal of Rheumatology, Epub ahead of print May 2011. doi:10.3109\/03009742.2011.573503.","DOI":"10.3109\/03009742.2011.573503"},{"key":"10.1016\/j.berh.2011.10.009_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.1780310306","article-title":"The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis","volume":"31","author":"Mitchell","year":"1988","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib10","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6","article-title":"A reappraisal of HAQ disability in rheumatoid arthritis","volume":"43","author":"Wolfe","year":"2000","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","article-title":"Co-morbidities in rheumatoid arthritis","volume":"21","author":"Michaud","year":"2007","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2009.118430","article-title":"Impact of comorbidity on physical function in patients with rheumatoid arthritis","volume":"69","author":"Radner","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/003591576305600924","article-title":"The prognosis of rheumatoid arthritis. (185 patients followed up over 13 years)","volume":"56","author":"Reah","year":"1963","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib14","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","article-title":"High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis","volume":"103","author":"Meune","year":"2010","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2796.2010.02260.x","article-title":"Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006","volume":"268","author":"Holmqvist","year":"2010","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"Douglas","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib21","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2011.10.009_bib23","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.berh.2011.10.009_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2010.02.040","article-title":"Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review","volume":"78","author":"Ruyssen-Witrand","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.berh.2011.10.009_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.berh.2011.10.009_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/rheumatology\/keq316","article-title":"Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"50","author":"Westlake","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cjca.2010.12.040","article-title":"Chronic inflammatory diseases and cardiovascular risk: a systematic review","volume":"27","author":"Roifman","year":"2011","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1016\/j.berh.2011.10.009_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.1780080504","article-title":"The osteoporosis of rheumatoid arthritis","volume":"8","author":"Duncan","year":"1965","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2011.10.009_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncprheum0036","article-title":"Mechanisms of Disease: the link between RANKL and arthritic bone disease","volume":"1","author":"Schett","year":"2005","journal-title":"Nature Clinical Practice Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2011.10.009_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Research"},{"key":"10.1016\/j.berh.2011.10.009_bib32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780271205","article-title":"Fractures after rheumatoid arthritis. A population-based study","volume":"27","author":"Hooyman","year":"1984","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0049-0172(91)90021-Q","article-title":"Osteoporosis associated with rheumatoid arthritis: pathogenesis and management","volume":"20","author":"Joffe","year":"1991","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0953-6205(02)00129-2","article-title":"Peripheral bone density in patients with rheumatoid arthritis and factors which influence it","volume":"13","author":"Kelly","year":"2002","journal-title":"European Journal of Internal Medicine"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis & Rheumatism"},{"issue":"6","key":"10.1016\/j.berh.2011.10.009_bib36","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/art.24551","article-title":"The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis","volume":"60","author":"Solomon","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/RHU.0b013e3181a5679d","article-title":"Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry","volume":"15","author":"Coulson","year":"2009","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib38","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/rheumatology\/keq181","article-title":"Disease activity and severity in early inflammatory arthritis predict hand cortical bone loss","volume":"49","author":"Pye","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/keq084","article-title":"Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment","volume":"49","author":"El Maghraoui","year":"2010","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke","volume":"70","author":"K\u00e4llberg","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2011.10.009_bib41","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1902\/jop.2000.71.12.1874","article-title":"Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss","volume":"71","author":"Albandar","year":"2000","journal-title":"Journal of Periodontology"},{"issue":"5","key":"10.1016\/j.berh.2011.10.009_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00011-011-0308-7","article-title":"Impact of smoking on inflammation: overview of molecular mechanisms","volume":"60","author":"Gon\u00e7alves","year":"2011","journal-title":"Inflammation Research"},{"issue":"7","key":"10.1016\/j.berh.2011.10.009_bib43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2005.036913","article-title":"The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction","volume":"65","author":"Marotte","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2011.10.009_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1034\/j.1600-0765.2003.00683.x","article-title":"Are there HLA combinations typical supporting for or making resistant against aggressive and\/or chronic periodontitis?","volume":"38","author":"Stein","year":"2003","journal-title":"Journal of Periodontal Research"},{"issue":"4","key":"10.1016\/j.berh.2011.10.009_bib45","first-page":"188","article-title":"Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations","volume":"30","author":"Smolik","year":"2009","journal-title":"Compendium of Continuing Education in Dentistry"},{"key":"10.1016\/j.berh.2011.10.009_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar3106","article-title":"The association between rheumatoid arthritis and periodontal disease","volume":"12","author":"Detert","year":"2010","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2011.10.009_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1902\/jop.2008.070501","article-title":"Association among rheumatoid arthritis, oral hygiene, and periodontitis","volume":"79","author":"Pischon","year":"2008","journal-title":"Journal of Periodontology"},{"key":"10.1016\/j.berh.2011.10.009_bib48","first-page":"70","article-title":"Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population","volume":"35","author":"de Pablo","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10620-010-1508-7","article-title":"Gastrointestinal and hepatic manifestations of rheumatoid arthritis","volume":"56","author":"Ebert","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"2 Pt 2 Suppl","key":"10.1016\/j.berh.2011.10.009_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0016-5085(89)80061-7","article-title":"Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use","volume":"96","author":"Fries","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2011.10.009_bib51","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/art.20440","article-title":"The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis","volume":"50","author":"Fries","year":"2004","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/ard.2006.068015","article-title":"Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis","volume":"67","author":"Steen","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198307073090105","article-title":"Association of adrenocorticosteroid therapy and peptic-ulcer disease","volume":"309","author":"Messer","year":"1983","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/art.30107","article-title":"The incidence of gastrointestinal perforations among rheumatoid arthritis patients","volume":"63","author":"Curtis","year":"2011","journal-title":"Arthritis & Rheumatism"},{"issue":"19","key":"10.1016\/j.berh.2011.10.009_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00535-008-2266-6","article-title":"Intestinal permeability in the pathogenesis of NSAID-induced enteropathy","volume":"44","author":"Bjarnason","year":"2009","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.berh.2011.10.009_bib56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.2005.039586","article-title":"Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?","volume":"82","author":"Adebayo","year":"2006","journal-title":"Journal of Postgraduate Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","article-title":"Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study","volume":"5","author":"Maiden","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.berh.2011.10.009_bib58","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/BF02049158","article-title":"Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine","volume":"38","author":"Davies","year":"1995","journal-title":"Diseases of the Colon & Rectum"},{"key":"10.1016\/j.berh.2011.10.009_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1463-1318.2009.01948.x","article-title":"Colonic mucosal lesions associated with long-term or short-term administration of nonsteroidal anti-inflammatory drugs","volume":"12","author":"Shibuya","year":"2010","journal-title":"Colorectal Disease"},{"issue":"11","key":"10.1016\/j.berh.2011.10.009_bib60","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10067-011-1827-x","article-title":"Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review","volume":"30","author":"Gout","year":"2011","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10165-010-0279-5","article-title":"Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions","volume":"20","author":"Nishimoto","year":"2010","journal-title":"Modern Rheumatology"},{"issue":"Suppl","key":"10.1016\/j.berh.2011.10.009_bib62","first-page":"S602","article-title":"Gastrointestinal safety in patients with rheumatoid arthritis treated with tocilizumab: data from Roche clinical trials","volume":"60","author":"van Vollenhoven","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ard.30.2.166","article-title":"Serum biochemical values in rheumatoid disease","volume":"30","author":"Cockel","year":"1971","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib64","first-page":"507","article-title":"Chronic hepatitis during rheumatoid arthritis","volume":"9","author":"Job-Deslandre","year":"1991","journal-title":"Clinical & Experimental Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib65","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3085","article-title":"Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes","volume":"12","author":"Quintin","year":"2010","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2011.10.009_bib66","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study","volume":"53","author":"Laharie","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.berh.2011.10.009_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ard.2008.101378","article-title":"Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and\/or leflunomide","volume":"69","author":"Curtis","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib68","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","article-title":"Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.berh.2011.10.009_bib69","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ajg.2008.149","article-title":"How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial","volume":"104","author":"Laine","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/j.berh.2011.10.009_bib70","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2011.10.009_bib71","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2011.10.009_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.berh.2011.10.009_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatology International"},{"issue":"6","key":"10.1016\/j.berh.2011.10.009_bib74","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of\u00a0interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis & Rheumatism"},{"issue":"6","key":"10.1016\/j.berh.2011.10.009_bib75","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib76","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009741003604542","article-title":"Mortality and cause of death in Japanese patients with\u00a0rheumatoid arthritis based on a large observational cohort, IORRA","volume":"39","author":"Nakajima","year":"2010","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib78","first-page":"51","article-title":"Can baseline pulmonary functions tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis?","volume":"7","author":"Howes","year":"1999","journal-title":"Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib79","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.168.17.1927","article-title":"Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gaffo","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib80","first-page":"622","article-title":"Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis","volume":"33","author":"\u00d6st\u00f6r","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2011.10.009_bib82","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.22666","article-title":"Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis","volume":"56","author":"Ju","year":"2007","journal-title":"Arthritis & Rheumatism"},{"issue":"18","key":"10.1016\/j.berh.2011.10.009_bib83","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1517\/14656560802591430","article-title":"Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease","volume":"9","author":"Kelly","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.berh.2011.10.009_bib84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20\u00a0+\u00a0B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib85","doi-asserted-by":"crossref","DOI":"10.1177\/1753465811407786","article-title":"Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids","author":"Haroon","year":"2011","journal-title":"Therapeutic Advances in Respiratory Disease"},{"key":"10.1016\/j.berh.2011.10.009_bib86","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Research & Therapy"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib87","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3816\/CLM.2008.n.009","article-title":"Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature","volume":"8","author":"Kaiser","year":"2008","journal-title":"Clinical Lymphoma & Myeloma"},{"key":"10.1016\/j.berh.2011.10.009_bib89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/rheumatology\/35.8.738","article-title":"Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study","volume":"35","author":"Jones","year":"1996","journal-title":"British Journal of Rheumatology"},{"issue":"18","key":"10.1016\/j.berh.2011.10.009_bib90","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib91","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis & Rheumatism"},{"issue":"9","key":"10.1016\/j.berh.2011.10.009_bib92","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib93","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/rheumatology\/ker113","article-title":"Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis","volume":"50","author":"Amari","year":"2011","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2011.10.009_bib94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.autrev.2009.07.006","article-title":"Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry","volume":"9","author":"Pallavicini","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"11","key":"10.1016\/j.berh.2011.10.009_bib96","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/art.24941","article-title":"Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?","volume":"60","author":"Askling","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2011.10.009_bib97","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar2904","article-title":"Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT","volume":"12","author":"Strangfeld","year":"2010","journal-title":"Arthritis Research & Therapy"},{"issue":"9","key":"10.1016\/j.berh.2011.10.009_bib98","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis & Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2011.10.009_bib99","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.23913","article-title":"Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis","volume":"59","author":"Lacaille","year":"2008","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2011.10.009_bib100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jbspin.2010.02.009","article-title":"Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review","volume":"77","author":"Ruyssen-Witrand","year":"2010","journal-title":"Joint, Bone, Spine"},{"issue":"2","key":"10.1016\/j.berh.2011.10.009_bib101","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","author":"Greenberg","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1016\/j.berh.2011.10.009_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MD.0b013e318211106a","article-title":"TNF-alpha antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis","volume":"90","author":"Lane","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.berh.2011.10.009_bib103","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib104","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib105","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib106","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.berh.2011.10.009_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2007.083188","article-title":"Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials","volume":"68","author":"Saillot","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib108","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","article-title":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials","volume":"50","author":"Campbell","year":"2011","journal-title":"Rheumatology"},{"issue":"Suppl II","key":"10.1016\/j.berh.2011.10.009_bib109","first-page":"88","article-title":"Long-term safety data from extended follow-up and repeat use of rituximab in rheumatoid arthritis","volume":"66","author":"van Vollenhoven","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2011.10.009_bib110","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/art.23112","article-title":"The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom","volume":"57","author":"Smitten","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2011.10.009_bib111","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","author":"Strangfield","year":"2009","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.berh.2011.10.009_bib112","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11537510-000000000-00000","article-title":"Progressive multifocal leukoencephalopathy and newer biological agents","volume":"33","author":"Berger","year":"2010","journal-title":"Drug Safety"},{"key":"10.1016\/j.berh.2011.10.009_bib113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2007.11.013","article-title":"The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases","volume":"30","author":"Boren","year":"2008","journal-title":"Journal of autoimmunity"},{"key":"10.1016\/j.berh.2011.10.009_bib114","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis & Rheumatism"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694211000842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694211000842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T13:44:18Z","timestamp":1593351858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694211000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1521694211000842"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2011.10.009","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}